SCHEMBL4880966

SCHEMBL4880966

CCCCCCCCCNC(=O)C(O)c1ccc(OC)cc1

nearest known ligand 0.70

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.70
HSD17B10 Q99714 1/20 0.57
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
ALDH1A1 P00352 1/20 0.50
MGLL Q99685 1/20 0.48
GLS O94925 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705005 1.00 NAAA (0.70) NAAAHSD17B10NPC1RAB9AALDH1A1
SCHEMBL4882322 1.00 NAAA (0.70) NAAAHSD17B10NPC1RAB9AALDH1A1
SCHEMBL6387020 0.84 NAAA (0.76) NAAA
SCHEMBL4881390 0.84 NAAA (0.76) NAAA
SCHEMBL6388581 0.84 NAAA (0.76) NAAA
SCHEMBL6258955 0.81 NAAA (0.97) NAAAALDH1A1
SCHEMBL4881044 0.81 NAAA (0.59) NAAAMGLL
SCHEMBL2121870 0.81 NAAA (0.59) NAAA
SCHEMBL4886844 0.81 NAAA (0.59) NAAAMGLL
SCHEMBL5704957 0.81 NAAA (0.59) NAAAMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515943-B1 USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS SYMRISE GMBH & CO KG (DE) 2006-08-30 EP claimed
US-20050208084-A1 Use of alkylamidomandelates as flavourings SYMRISE GMBH & CO. KG (DE) 2005-09-22 US claimed
US-20080038386-A1 Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition MOZA ASHOK K 2008-02-14 US disclosed
US-20050208084-A1 Use of alkylamidomandelates as flavourings SYMRISE GMBH & CO. KG (DE) 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050208084-A1 Use of alkylamidomandelates as flavourings HNMT, TAS2R7, PNMT NAAA 4/4885HSD17B10 923/4885NPC1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.